Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Ardelyx Inc (ARDX)

0.8451   0.016 (1.97%) 01-26 00:07
Open: 0.84 Pre. Close: 0.8288
High: 0.88 Low: 0.8256
Volume: 2,400,805 Market Cap: 95M
Ardelyx, Inc., a biopharmaceutical company, develops and sells medicines for the treatment of kidney and cardiorenal diseases in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase 3 clinical trial for the treatment of patients with irritable bowel syndrome with constipation, as well as in Phase 3 clinical trial for the treatment of hyperphosphatemia in end-stage renal disease patients on dialysis. It also develops RDX013, a small molecule potassium secretagogue program that is in Phase 2 clinical trial for the treatment of patients with hyperkalemia; and RDX020, a small molecule program for the treatment of metabolic acidosis. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. Ardelyx, Inc. was incorporated in 2007 and is headquartered in Fremont, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.88 - 0.886 0.886 - 0.891
Low: 0.818 - 0.824 0.824 - 0.83
Close: 0.841 - 0.85 0.85 - 0.858

Technical analysis

as of: 2022-01-25 4:22:12 PM
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 1.27     One year: 1.51
Support: Support1: 0.75    Support2: 0.62
Resistance: Resistance1: 1.08    Resistance2: 1.29
Pivot: 0.94
Moving Average: MA(5): 0.86     MA(20): 0.98
MA(100): 1.18     MA(250): 4.06
MACD: MACD(12,26): -0.09     Signal(9): -0.07
Stochastic oscillator: %K(14,3): 14.73     %D(3): 9.30
RSI: RSI(14): 35.07
52-week: High: 9.23  Low: 0.75  Change(%): -87.6
Average Vol(K): 3-Month: 18104  10-Days: 3020

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
ARDX has closed above bottom band by 18.2%. Bollinger Bands are 20.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 12 Jan 2022
Ardelyx pivots back to the start with irritable bowel syndrome drug launch - San Francisco Business Times - San Francisco Business Times

Mon, 03 Jan 2022
Is Ardelyx Inc (ARDX) a Stock to Watch After Gaining 4.63% This Week? - InvestorsObserver

Tue, 28 Dec 2021
Are Options Traders Betting on a Big Move in Ardelyx (ARDX) Stock? - Nasdaq

Wed, 08 Dec 2021
Should You Sell Ardelyx Inc (ARDX) Stock Wednesday Morning? - InvestorsObserver

Mon, 06 Dec 2021
Should You Hold Ardelyx Inc (ARDX) Stock Monday Morning? - InvestorsObserver

Thu, 04 Nov 2021
Ardelyx to Pursue Formal Dispute Resolution for Tenapanor - PRNewswire

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 113
Shares Float (M) 99
% Held by Insiders 2.70
% Held by Institutions 46.32
Shares Short (K) 8,010
Shares Short P. Month (K) 6,340

Stock Financials

EPS -1.537
EPS Est This Year -2.200
EPS Est Next Year -2.120
Book Value (p.s.) 0.760
Profit Margin
Operating Margin -1315.77
Return on Assets (ttm) -48.4
Return on Equity (ttm) -141.8
Qtrly Rev. Growth -56.8
Gross Profit (p.s.) -0.511
Sales Per Share 0.097
EBITDA (p.s.) -1.255
Qtrly Earnings Growth
Operating Cash Flow (M) -131
Levered Free Cash Flow (M) -77

Stock Valuations

PE Ratio -0.55
PEG Ratio
Price to Book value 1.11
Price to Sales 8.76
Price to Cash Flow

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.